Though less common, it carries a higher risk of spreading to other areas of the body. When bladder cancer spreads to distant ...

for bladder cancer may improve outcomes. The research, published in the journal Urologic Oncology: Seminars and Original Investigations, focused on metastatic urothelial carcinoma (mUC), cancer ...

N1 Single lymph node metastasis, 2 cm or less in greatest ... The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% ...

Extracellular DNA in patients with urothelial carcinoma of the bladder. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text ...

Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies ...

Discover a study that found that the combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible ...

Evaluating the contribution of circulating tumor DNA (ctDNA) towards magnetic resonance imaging (MRI) in clinical staging and response assessment of patients with muscle-invasive bladder cancer (MIBC) ...

Given different scientific and clinical meeting schedules, considering advances in genitourinary oncology in novel therapies ...

Bone metastases are cancers that have spread (metastasized) from other tissues in the body through the blood or lymphatic systems to the bone marrow. Bone metastases form the main type of bone ...